Getein Biotech, Inc. (603387.SH) disclosed its third quarter report for 2024, achieving revenue of 8...
China Finance App reports that Getein Biotech, Inc. (603387.SH) disclosed its third quarter report for 2024, with the company achieving revenue of 0.88 billion yuan, a 12.10% year-on-year decrease; net income attributable to shareholders of 0.202 billion yuan, a 11.69% year-on-year decrease; non-GAAP net income of 0.176 billion yuan, a 11.29% year-on-year decrease; and basic earnings per share of 0.40 yuan.